Filter your search
Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging
- $1,995.00 – $3,995.00IVD manufacturers on the lookout for growth have targeted the Philippines among other places. Expanding economies worldwide need to increase healthcare spending to satisfy growing middle and low-to-middle class populations. IVD performs where healthcare spending increases as it is often the entry point of healthcare. This report, IVD Distribution in The Philippines, reviews the distribution […]February 5, 2014$1,995.00 – $3,990.00Medical Imaging Markets (X-Ray, CT, MRI, Ultrasound, PET, SPECT, Others) Medical imaging’s contributions to medical practice has made it an ever-growing industry with new technologies constantly being launched. Early and more accurate diagnoses are made possible via imaging scans, which in turn may lead to optimized treatment regimens. The Medical Imaging Markets report reviews current […]February 5, 2014$2,995.00 – $5,990.00The Market and Potential for Molecular Point of Care Diagnostics Molecular Point of Care is a budding field in medical diagnostics. Kalorama’s report, The Market and Potential for Molecular Point of Care Diagnostics, provides the most current look at this field. To assess the opportunity, Kalorama’s report examines the molecular diagnostics business and also the […]February 5, 2014Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology. […]January 14, 2014$1,995.00 – $3,995.00IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. […]January 1, 2014$3,995.00 – $7,990.00The market for clinical lab services is dynamic. It is estimated that approximately 80% of physician’s diagnoses are a result of laboratory tests, and a fair number of these tests are sent to clinical lab service providers. There is constant pressure to reduce healthcare spending, and that in turn is shifting healthcare utilization in favor […]December 20, 2013$995.00 – $1,990.00Full coverage of the IVD market in Mexico, including important IVD segments.December 16, 2013$1,995.00 – $4,000.00The World Market for Hematology Used for both critical and routine testing, hematology is a central part of IVD. CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin deficiencies are easily diagnosed through a CBC. This report, authored by […]November 22, 2013$3,995.00 – $7,990.00The World Market for Immunoassays Visit our Immunoassays curated page for complete industry coverage. The immunoassay market is large and long-established, but at the same time highly competitive. Kalorama Information’s newly published report, The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting new strategies and for new entrants to […]November 6, 2013$1,995.00 – $3,900.00What is the procedure, for establishing reimbursement for an IVD test product? What companies have been successful and how? What changes will IVD makers face in the near-term. This Kalorama Information report, Reimbursement for In Vitro Diagnostic Tests, answers these questions and provides authoritative data for IVD business planners. One of the critical factors for […]October 25, 2013